Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level
| Brand name | METFORMIN HYDROCHLORIDE EXTENDED RELEASE |
| Generic name | METFORMIN HYDROCHLORIDE |
| Active ingredient(s) | METFORMIN HYDROCHLORIDE |
| Distributed by / for | Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA |
| NDC | 49483-623-01 |
| Full product label | Time-Cap Labs, Inc. Metformin Hydrochloride Extended-Release Tablets, USP 500 mg Rx Only 100 Tablets bottles, Manufactured for: Time-Cap Labs, Inc. 7 Michael Avenue Farmingdale, NY 11735, USA Manufactured by: Marksans Pharma Ltd. Plot No, L-82, L-83, Verna Intl. Estate, Verna, Goa-403 722, India NDC 49483-623-01 |
| Recalling firm | Marksans Pharma Limited |
| Distribution | Nationwide |
| Quantity | 11279 bottles |
| Recall initiated | 2020-06-05 |
| Report date | 2020-07-01 |
| Recall completed | 2023-09-07 |
| Recall number | D-1356-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Vasco Da Gama N/A India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗